The Influence of Lymph Node Count on Oncological Outcome of Radical Cystectomy in Chemotherapy Pre-Treated and Chemotherapy-Naïve Patients with Muscle Invasive Bladder Cancer

par Artur Lemiński, Krystian Kaczmarek, Wojciech Michalski, Bartosz Małkiewicz, Katarzyna Kotfis, Marcin Słojewski
Publié 2021

Outcomes of neoadjuvant chemotherapy in resectable, borderline resectable and locally advanced pancreatic cancer

par Kamil D. Dalgatov, Nikolai N. Semenov, Margarita V. Kozodaeva
Publié 2021

Clinicopathological Analysis and Demographic Features of Ocular Malignancies

par Al-Mujaini A, Maurya RP, Bosak S, Karan MK, Roy M, Singh VP, Singh MK, Kumar A, Singh S
Publié 2021

Machine Learning-Based Radiomics Nomogram With Dynamic Contrast-Enhanced MRI of the Osteosarcoma for Evaluation of Efficacy of Neoadjuvant Chemotherapy

par Lu Zhang, Yinghui Ge, Qiuru Gao, Fei Zhao, Tianming Cheng, Hailiang Li, Yuwei Xia
Publié 2021

A Combined Nomogram Model to Predict Disease-free Survival in Triple-Negative Breast Cancer Patients With Neoadjuvant Chemotherapy

par Bingqing Xia, Bingqing Xia, He Wang, Zhe Wang, Zhaoxia Qian, Qin Xiao, Yin Liu, Zhimin Shao, Shuling Zhou, Weimin Chai, Chao You, Yajia Gu
Publié 2021

Neoadjuvant docetaxel, oxaliplatin plus S-1 for treating clinical stage III squamous cell carcinoma of the esophagus: Study protocol of an open-label phase II trial

par Mitsuro Kanda, Dai Shimizu, Kazushi Miyata, Osamu Maeda, Chie Tanaka, Yoshikuni Inokawa, Norofumi Hattori, Masamichi Hayashi, Masahiko Ando, Yachiyo Kuwatsuka, Kenta Murotani, Goro Nakayama, Masahiko Koike, Yuichi Ando, Tomoki Ebata, Yasuhiro Kodera
Publié 2021

A mouse model of neoadjuvant chemotherapy followed by interval cytoreductive surgery indicates impaired efficacy of perioperative cisplatin

par Mitchell Clark, Alexandra Kollara, Theodore J. Brown, Taymaa May
Publié 2021

Characteristics and Risk Factors of Postoperative Complications in Gastric Cancer Patients Treated with Neoadjuvant Chemotherapy

par SUN Chongyuan, ZHAO Dongbing
Publié 2021

Mechanisms behind prometastatic changes induced by neoadjuvant chemotherapy in the breast cancer microenvironment

par Perelmuter VM, Tashireva LA, Savelieva OE, Denisov EV, Kaigorodova EV, Zavyalova MV, Cherdyntseva NV
Publié 2019

A Comparison of Different Schemes of Neoadjuvant Chemotherapy Followed by Concurrent Chemotherapy and Radiotherapy for Locally Advanced Cervical Cancer: A Retrospective Study

par Tian X, Yang F, Li F, Ran L, Chang J, Li J, Hong W, Shan L, Du Y, Hu L, Mei F, He M, Li Y, Wang H, Zuo K, Zhou B, Chen S, Mao W
Publié 2021

Nasopharyngeal carcinoma – Improving cure with technology and clinical trials

par Raymond K. Tsang
Publié 2020

Mirna21 Expression in the Breast Cancer Tumor Tissue is Independent of Neoadjuvant Chemotherapy

par Sales ACV, Gomes da Silva IIF, Leite MCB, Coutinho LL, Reis RBAC, Castoldi A, B. G. Martins D, Lima-Filho JL, Souto FO
Publié 2020

Molecular Biomarkers Predict Pathological Complete Response of Neoadjuvant Chemotherapy in Breast Cancer Patients: Review

par Ana Julia Aguiar de Freitas, Rhafaela Lima Causin, Muriele Bertagna Varuzza, Cassio Murilo Trovo Hidalgo Filho, Vinicius Duval da Silva, Cristiano de Pádua Souza, Márcia Maria Chiquitelli Marques
Publié 2021

Predicting Pathological Complete Response After Neoadjuvant Chemotherapy in Advanced Breast Cancer by Ultrasound and Clinicopathological Features Using a Nomogram

par Hao Cui, Dantong Zhao, Peng Han, Xudong Zhang, Wei Fan, Xiaoxuan Zuo, Panting Wang, Nana Hu, Hanqing Kong, Fuhui Peng, Ying Wang, Jiawei Tian, Lei Zhang
Publié 2021

Management of Ovarian Yolk Sac Tumor in Pregnancy in a Limited Resource Setting: Case Report

par Tofan Utami, Herdhana Suwartono, Erda Umami, Anggara Mahardika, Raymond Surya, Laila Nurana
Publié 2021

Approaching Neoadjuvant Therapy in the Management of Early-Stage Breast Cancer

par Hyder T, Bhattacharya S, Gade K, Nasrazadani A, Brufsky AM
Publié 2021

Decrease in Blood Neutrophil-to-Lymphocyte Ratio Indicates Better Survival After Neoadjuvant Chemotherapy in Patients With Advanced Gastric Cancer

par Ziyi Liu, Yahang Liang, Xiaolong Tang, Hui Qu
Publié 2021

Influence of correction of nutritive deficiency on the effectiveness of neoadjuvant chemotherapy in patients with locally advanced gastric cancer

par Nadezhda A. Brish, Tatiana Yu. Semiglazova, Aleksei M. Karachun, Lev N. Shevkunov, Yana A. Ulyanchenko, Anna S. Artemyeva, Tatiana S. Golovanova, Elena V. Tkachenko, Yuliia V. Alexeeva, Sofiko M. Sharashenidze, Liubov V. Strakh, Svetlana A. Protsenko, Gulfiia M. Teletaeva, Larisa V. Filatova, Boris S. Kasparov, Vladislav V. Semiglazov, Aleksei M. Belyaev
Publié 2021

Application of Gross Tissue Response System in Gastric Cancer After Neoadjuvant Chemotherapy: A Primary Report of a Prospective Cohort Study

par Hua Yang, Wei-Han Zhang, Rui Ge, Bo-Qiang Peng, Xin-Zu Chen, Kun Yang, Kai Liu, Xiao-Long Chen, Du He, Jian-Ping Liu, Wei-Wei Zhang, Yun Qin, Zong-Guang Zhou, Jian-Kun Hu
Publié 2021

Association of tumor‐infiltrating lymphocytes before and after neoadjuvant chemotherapy with pathological complete response and prognosis in patients with breast cancer

par Jin Hong, Weiwei Rui, Xiaochun Fei, Xiaosong Chen, Kunwei Shen
Publié 2021